TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo
Collections
Citation
Ryang Hwa Lee; Ji Min Yu; Andrea M. Foskett; Grant Peltier; John C. Reneau; Nikolay Bazhanov; Joo Youn Oh; Darwin J. Prockop (2014). TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proceedings of the National Academy of Sciences of the United States of America. Available electronically from https : / /hdl .handle .net /1969 .1 /182159.